It remains to determine the link between hyperhomocysteinemia, low folate intake, CAD risk, and MTHFR variants, to explain this prevalence in Turkey and possibly in other countries of the MENA region. The gene discussed is MTHFR; the disease is hyperhomocysteinemia.